$LUCD SEC Filings

Filed On	Filing
22 Oct 2026	8-K: Unregistered Sales of Equity Securities; Material Modifications to Rights of Security Holders +1 more He is the Chief Executive Officer of Lucid Diagnostics Inc., a Delaware corporation (the “Corporation”).
16 Oct 2026	8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
22 Sep 2026	8-K: Regulation FD Disclosure Medicare Advisory Panel recommends maintaining EsoGuard’s original gapfill payment basis under the Clinical Laboratory Fee Schedule
13 Aug 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
12 Aug 2026	FORM 10-Q
24 Jun 2026	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders
21 May 2026	Form 4: Matheis Dennis, Director Bought 245,000 shares ($245K)
14 May 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
13 May 2026	FORM 10-Q
30 Apr 2026	DEFA14A
30 Apr 2026	ARS
30 Apr 2026	Proxy statement: annual meeting on June 24, 2026
24 Apr 2026	Form 3/A: Lee Victoria Tou-ho, Chief Medical Officer Holds 650,000 shares of Common Stock
24 Apr 2026	8-K: Regulation FD Disclosure; Other Events
23 Apr 2026	424B5
23 Apr 2026	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
20 Apr 2026	PRE 14A
13 Apr 2026	Form 3: Lee Victoria Tou-ho, Chief Medical Officer Holds 650,000 shares of Common Stock
03 Apr 2026	S-8
03 Apr 2026	S-8

Comments